Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
Most people are familiar with melanoma as a skin cancer, but melanoma can impact the eyes as well. Brian Marr, MD, offers tips on how to protect your eyes.
A new study in mice, led by Columbia University researchers, suggests experimental eye drops may be more effective than injections for treatment of retinal vein occlusion, a major cause of blindness.